PMID- 23029541 OWN - NLM STAT- MEDLINE DCOM- 20130220 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 9 DP - 2012 TI - Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PG - e46504 LID - 10.1371/journal.pone.0046504 [doi] LID - e46504 AB - It is unknown whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can improve the renal function of patients suffering from acute kidney injury. Moreover, before beginning clinical trials, it is necessary to investigate this renoprotective effect of hUC-MSCs in a xenogeneic model of acute kidney injury. However, no previous studies have examined the application of hUC-MSCs to immunodeficient mice suffering from acute kidney injury. The objectives of this study were to examine whether hUC-MSCs could improve renal function in nonobese diabetic-severe combined immune deficiency (NOD-SCID) mice suffering from acute kidney injury, and to investigate the mechanism(s) for hUC-MSCs to improve renal function in this xenogeneic model. Early (3 hr) and late (12 hr) administrations of hUC-MSCs (10(6) cells) were performed via the external jugular vein into NOD-SCID mice suffering from either folic acid (FA) (250 mg/kg body weight) or vehicle. The results showed that early administration of hUC-MSCs improved the renal function of NOD-SCID mice suffering from FA-induced acute kidney injury, as evidenced by decreased serum urea nitrogen and serum creatinine levels, as well as a reduced tubular injury score. The beneficial effects of hUC-MSCs were through reducing apoptosis and promoting proliferation of renal tubular cells. These benefits were independent of inflammatory cytokine effects and transdifferentiation. Furthermore, this study is the first one to show that the reduced apoptosis of renal tubular cells by hUC-MSCs in this xenogeneic model is mediated through the mitochondrial pathway, and through the increase of Akt phosphorylation. FAU - Fang, Te-Chao AU - Fang TC AD - Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan. fangtechao@yahoo.com.tw FAU - Pang, Cheng-Yoong AU - Pang CY FAU - Chiu, Sheng-Chun AU - Chiu SC FAU - Ding, Dah-Ching AU - Ding DC FAU - Tsai, Rong-Kung AU - Tsai RK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120927 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Antigens, CD) RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 935E97BOY8 (Folic Acid) RN - AYI8EX34EU (Creatinine) RN - EC 3.4.22.- (Caspases) SB - IM MH - Acute Kidney Injury/blood/chemically induced/*therapy MH - Animals MH - Antigens, CD/metabolism MH - Apoptosis MH - Blood Urea Nitrogen MH - Caspases/metabolism MH - Cell Differentiation MH - Cell Proliferation MH - Creatinine/blood MH - Cytokines/metabolism MH - Cytoprotection MH - Folic Acid MH - Humans MH - Inflammation Mediators/metabolism MH - Insulin-Like Growth Factor I/metabolism MH - Kidney Tubules/metabolism/pathology/physiopathology MH - Male MH - *Mesenchymal Stem Cell Transplantation MH - Mesenchymal Stem Cells/metabolism/*physiology MH - Mice MH - Mice, Inbred NOD MH - Mice, SCID MH - Tissue Array Analysis MH - Umbilical Cord/cytology MH - Wharton Jelly/*cytology PMC - PMC3459926 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/10/03 06:00 MHDA- 2013/02/21 06:00 PMCR- 2012/09/27 CRDT- 2012/10/03 06:00 PHST- 2012/02/13 00:00 [received] PHST- 2012/09/03 00:00 [accepted] PHST- 2012/10/03 06:00 [entrez] PHST- 2012/10/03 06:00 [pubmed] PHST- 2013/02/21 06:00 [medline] PHST- 2012/09/27 00:00 [pmc-release] AID - PONE-D-12-04486 [pii] AID - 10.1371/journal.pone.0046504 [doi] PST - ppublish SO - PLoS One. 2012;7(9):e46504. doi: 10.1371/journal.pone.0046504. Epub 2012 Sep 27.